Psilocybin compositions
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
1. A composition comprising:
0.1 mg to 10 mg of psilocybin or psilocin;
an extract of Hericium erinaceus comprising 50 mg to 200 mg of erinacines or hericenones; and
199 mg of one or more medicinal mushroom species of Inonotus mycelia, fruitbodies, mycelial extracts, fruitbody extracts, or combinations thereof.
2. The composition of claim 1 , wherein the composition further comprises niacin.
3. The composition of claim 1 , wherein the composition further comprises one or more of: mycelia, fruitbodies, mycelial extracts, or fruitbody extracts of fungi selected from the group consisting of Antrodia, Beauveria, Copelandia, Cordyceps, Ganoderma, Grifola, Hericium, Isaria, Panaeolus, Phellinus or combinations thereof.
4. The composition of claim 1 , wherein the composition further comprises neurotropic or nootropic fungal or plant extracts.
5. The composition of claim 1 , wherein the composition further comprises one or more extracts of: Bacopa monnieri, Centella asiatica, Gingko biloba, Zingiber officinale, Ocimum sanctum, Polygonum cuspid atum, Origanum vulgare, Origanum onites, Rosmarinus species, Curcuma longa, Camellia sinensis, Lavandula species, Scutellaria lateriflora, Avena sativa, Avena byzantine, Salvia divinorum, Banisteriopsis caapi, Psychotria species, Tabemanthe iboga, Voacanga africana, Tabemaemontana undulate, Ipomoea tricolor, Argyreia nervosa, Cannabis sativa, Cannabis indica, Cannabis ruderalis , or combinations thereof.
6. A composition comprising:
0.1 to 10 mg of psilocybin or psilocin;
an extract of Hericium erinaceus comprising 50 mg to 200 mg of erinacines or hericenones;
199 mg of one or more medicinal mushroom species of Inonotus mycelia, fruitbodies, mycelial extracts, fruitbody extracts or combinations thereof, and
niacin.
7. The composition of claim 6 , wherein the composition further comprises one or more of: mycelia, fruitbodies, mycelial extracts, or fruitbody extracts of fungi selected from the group consisting of Antrodia, Beauveria, Copelandia, Cordyceps, Ganoderma, Grifola, Hericium, Isaria, Panaeolus, Phellinus or combinations thereof.
8. The composition of claim 6 , wherein the composition further comprises neurotropic or nootropic fungal or plant extracts.
9. The composition of claim 6 , wherein the composition further comprises one or more extracts of: Bacopa monnieri, Centella asiatica, Gingko biloba, Zingiber officinale, Ocimum sanctum, Polygonum cuspid atum, Origanum vulgare, Origanum onites, Rosmarinus species, Curcuma longa, Camellia sinensis, Lavandula species, Scutellaria lateriflora, Avena sativa, Avena byzantine, Salvia divinorum, Banisteriopsis caapi, Psychotria species, Tabemanthe iboga, Voacanga africana, Tabemaemontana undulate, Ipomoea tricolor, Argyreia nervosa, Cannabis sativa, Cannabis indica, Cannabis ruderalis , or combinations thereof.